hydroxychloroquine and Cacosmia
hydroxychloroquine has been researched along with Cacosmia in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bozzalla Cassione, E | 1 |
Zanframundo, G | 1 |
Biglia, A | 1 |
Codullo, V | 1 |
Montecucco, C | 1 |
Cavagna, L | 1 |
Kadono, Y | 1 |
Nakamura, Y | 1 |
Ogawa, Y | 1 |
Yamamoto, S | 1 |
Kajikawa, R | 1 |
Nakajima, Y | 1 |
Matsumoto, M | 1 |
Kishima, H | 1 |
Other Studies
2 other studies available for hydroxychloroquine and Cacosmia
Article | Year |
---|---|
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Labora | 2020 |
A case of COVID-19 infection presenting with a seizure following severe brain edema.
Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Anticonvulsants; Azithromycin; Betacoronavirus; Brain | 2020 |